Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
Lemack
Gary E
GE
University of Texas Southwestern Medical Center in Dallas, TX 75390-9110, USA. gary.lemack@utsouthwestern.edu
D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D011379:Prognosis; D011470:Prostatic Hyperplasia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D016482:Urinalysis; D001748:Urinary Bladder Neck Obstruction / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D053201:Urinary Bladder, Overactive / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000209:etiology / Q000517:prevention & control; D014563:Urodynamics
D018727:Muscarinic Antagonists